The current financial score of Chemours Co is 6.72. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 1.59B, representing a year-over-year decrease of 1.49%, while its net profit experienced a year-over-year decrease of 27.89%.
The current valuation score of Chemours Co is 9.62. Its current P/E ratio is -5.31, which is -1375.40% below the recent high of 67.76 and -1169.27% above the recent low of -67.43.
The current earnings forecast score of Chemours Co is 6.80. The average price target is 19.25, with a high of 24.00 and a low of 17.00.
The current price momentum score of Chemours Co is 3.48. Currently, the stock price is trading between the resistance level at 15.80 and the support level at 13.68, making it suitable for range-bound swing trading.
The current institutional shareholding score of Chemours Co is 10.00. The latest institutional shareholding proportion is 91.16%, representing a quarter-over-quarter decrease of 18.41%. The largest institutional shareholder is Private Capital, holding a total of 177.00K shares, representing 0.33% of shares outstanding, with 1.00% increase in holdings.
The current risk assessment score of Chemours Co is 4.93. The company's beta value is 1.41. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.